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Abstract 
Context  
Antibiotics are over-prescribed for children with upper respiratory infections (URIs), leading to unnecessary 
expenditures, adverse events and antibiotic resistance. 
Objective 
To assess whether interventions can reduce antibiotic prescription for childhood URIs and identify what factors 
impact intervention effectiveness. 
Data sources 
MEDLINE, EMBASE, Google Scholar, Web of Science - Global Health, WHO website, United States CDC 
website and The Cochrane Central Register of Controlled Trials (CENTRAL) were searched by August 2014.  
Study selection 
Cluster or individual patient randomized controlled trials (RCTs) and non-randomized controlled trials 
examining interventions to change antibiotic prescription rates (APR) for children with URIs were selected for 
meta-analysis. Educational interventions for clinicians and/or parents were compared with usual care. 
Results 
Of 6074 studies identified, thirteen were included. All were conducted in high-income countries. Educational 
interventions were associated with lower APR versus usual care (OR 0.65 (95% confidence interval [CI] 0.49-
0.86, P<0.001). A patient-clinician communication approach was the most effective type of intervention, with a 
pooled OR 0.41 (95% CI 0.20-0.83; P<0.001) for clinicians and a pooled OR for parents 0.26 (95%CI 0.08-0.91; 
P=0.04) compared with usual care. Compared with usual care, educational interventions that targeted both 
clinicians and parents were more effective than interventions for either group alone OR of 0.52 (95% CI 0.35-
0.78; P=0.002).  
Conclusion 
Educational interventions are effective in reducing antibiotic prescribing for childhood URIs. Interventions 
targeting both clinicians and parents are more effective than those for either group alone. The most effective 
interventions address patient-clinician communication. Studies in low-middle income countries are needed. 
Word (249) 
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Introduction  
Worldwide, inappropriate medication use is a major problem. According to the World Health Organization 
(WHO) 50% of medicines are prescribed, dispensed or sold inappropriately, while 50% of patients take their 
medicines incorrectly.1 Inappropriate antibiotic use can lead to antibiotic resistance, resulting in difficult or 
impossible to treat infections.2 Antibiotic resistance is more common in countries with high rates of antibiotic 
prescription.2  
Childhood upper respiratory infections (URIs) are very common, but are usually viral and self-limiting. 
Nevertheless prescribing antibiotics for childhood URIs is highly prevalent.3 Antibiotic resistance is frequently 
observed in young children and more invasive infections occur in this vulnerable population.4 In Asia, every 
two minutes a child under five years of age dies from antibiotic–resistant infections.5  
There are two main factors influencing inappropriate antibiotic use for childhood URIs - clinician prescribing 
and parent knowledge, attitude and demand.6 Educational interventions addressing these factors could reduce 
inappropriate antibiotic use. A Cochrane review showed that interventions involving physicians/pharmacists 
could reduce antibiotic prescription rates.7 However this review did not assess specifics of interventions (e.g., 
intervention type, the intervention target, intensity). Conflicting results were seen with parental interventions. 
One review found that parental interventions can influence knowledge and behavior, reducing consultation rates 
by 13% to 40%.3 However, another review showed that caregiver education may not be effective.8 Many 
published studies are descriptive, involving both adults and children with various diseases.9-12 This study aims 
to analyze the effectiveness of different intervention approaches, targeting different groups (clinicians, parents 
or both) and whether other factors – study setting, study design, study period - influence effectiveness for 
reducing antibiotic prescribing for childhood URIs.   
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Methods  
Search strategy 
We searched MEDLINE, EMBASE, Google scholar, Web of Science, Global Health, WHO website, United 
States CDC website and The Cochrane Central Register of Controlled Trials (CENTRAL) from 1980 to 
December 2015 for published articles without language restriction. Search terms included URIs, respiratory 
infections (RI), education, antibiotic prescription/prescribing, children/pediatric and antibiotic prescription rates. 
Two independent reviewers screened candidate studies using a structured form based on the PRISMA 2009 
four-phase flow diagram.   
Study selection  
We included studies according to PICOS (population, intervention, comparison, outcome, setting) 
characteristics by following professional interventions in the Effective Practice and Organization of Care group 
(EPOC) scope.13 
Population We included studies of children (<=18 years of age) diagnosed with any URI including rhinitis, 
sinusitis, pharyngitis, tonsillitis, acute otitis media or URI as a general category. To reduce misclassification 
bias, for studies that classified URI and these aforementioned specific categories as separate, we included all 
patients as they should be classified under the category of “URI” in our analysis. 
Intervention - Approaches for targeting clinicians, featuring: 1) Antibiotic prescription rate (APR) feedback; 2) 
Update and/or reinforcement of national guidelines; 3) Promoting delayed prescriptions; 4) Clinician-parent 
communication skills training and workshops. Intervention methods included: 1) Face to face training such as 
seminars, workshops or group discussion by trained peer leaders; 2) Indirect training, which included online 
workshops or pop-up messages through software or printed information related to appropriate antibiotic use.  
Approaches for targeting parents included: 1) Printed educational materials including leaflets/pamphlet or 
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posters; 2) Mass media such as video, radio and newspapers; 3) Clinician-patient communication, which 
included facilitating patient health literacy, explaning appropriate antibiotic use by clinicians.  
Comparator We included prospective studies with an intervention group compared to a control with usual care. 
Study designs were (clustered) randomized controlled trials and non-randomized controlled trials including 
cohort experimental studies.  
Outcome Studies with antibiotic prescription expressed either as a rate (%) or as numbers per person-time were 
included. APR was defined as the number of children who were prescribed one or more antibiotic classes 
divided by the total number of children assessed for URIs during a designated interval. 
Setting Studies from all geographic regions were eligible for inclusion. Study sites were included if they cared 
for children either in primary care/general practice or in specialty clinics. 
Quality assessment  
Quality was determined by two independent reviewers using the Cochrane risk of bias tool13, including domains 
related to sequence generation, allocation concealment, blinding, incomplete outcome data, selective reporting, 
intervention contamination, seasonal data collection and reporting of clustering coefficient. Each item outcome 
was categorized as high risk, low risk or unclear risk according to information provided. Disagreements 
between reviewers were resolved by discussion and consensus.  
Data extraction  
 
For the characteristic table, we extracted the following variables: study design, setting, follow up duration, 
children age, participants, details of interventions (target group, intervention content for clinician and parents, 
intervention technics), details of the comparator and outcome measures. To calculate the intervention group 
APR odds ratio (OR) we extracted the number of children or visits prescribed any antibiotic from both groups 
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as well as the total number of children or visits in each group. For studies that were designed as cluster 
randomized controlled trials (RCTs), we also extracted the intra-cluster correlation coefficients (ICCs) to adjust 
for design effect according to the Cochrane handbook.13 Furthermore, for studies with unknown ICC, we 
estimated from similar trials or by an approximated ICC.13 14 Studies with more than one control or time point 
were treated as if controls and time points were independent of each other.15   
Analysis  
Only studies with a calculable or reported APR were included into the meta-analysis. OR and 95% confidence 
interval (CI) were used to measure the effectiveness of intervention compared to usual care. Overall p value was 
used for the interaction between intervention and the estimates. We pooled studies using a Bayesian random-
effects model to account for variations across RCTs in populations, interventions, settings and other factors 
during meta-analyses.16 17 Heterogeneity across studies was evaluated using the I2 test. To explore heterogeneity 
source, meta-regressions were conducted for each potentially influential factor (target group, follow-up duration, 
region, design, year). For cluster studies additional factors (ICC reported or unreported, number of clusters, 
whether sites were pediatric clinics) were included. We also conducted a sensitivity analysis on individual 
studies to identify potential effects of outliers. For studies designed as cluster RCTs, we conducted another 
sensitivity analysis on ICC factors to determine if design effect influenced study outcome. According to the 
Cochrane handbook we selected three different ICC values (0.004, 0.02 and 0.2) for this sensitivity analysis. [18] 
For studies with more than one control group and time point within a study we also compared the result by 
merging effects within each study.15 Finally, we used a funnel plot with Egger’s regression test to assess for 
publication bias (p<0. 1). All analyses used STATA version 13.  
Results  
Description of included interventions  
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Of 6074 articles, 373 were accessed with full text. After exclusions 12 articles were eligible for meta-analysis 
(see Figure 1).   
Of the 12 studies included into this systematic review and meta-analysis, seven were cluster RCTs, three were 
non-randomized controlled trials and two were individual RCTs. One study had two control groups; one had 4 
outcomes with 3 different follow-up durations and one follow-up (12 months, 24 months, 36 months, 48 
months). Six studies were conducted in the United States (US), two in Israel, two in Norway, and one each in 
United Kingdom (UK), Iran, and Canada. Eight of 12 were conducted in primary care or general practices and 
the remaining four studies were conducted in pediatric practices. The study year ranged from 2000 to 2014, 
with follow-up duration lasting from one to 12 months. Finkelstein 200118 had two outcomes for age 3-36 
months and 36-72 months. Gonzales 200519 had two control groups with one located near to the intervention 
site and the other far from it. Regev-Yochay 201120 had 4 time point outcomes for different intervention types - 
year one was workshops for determinants of reducing antibiotic prescriptions, year two focused on patient-
clinician communication, year three involved workshops for APR feedback and year four was for follow-up 
after intervention. The cluster numbers ranged from two to 286 units, and the number of participating clinicians 
and registered patients ranged from 27 to 578 and 81 to 97699, respectively (Table 1). Nine articles were found 
to have low risk of bias, three had high risk (see Table 2). 
Intervention effects, all studies (Figure 2)  
Based on heterogeneity we used random-effects to deal with differences among studies. We combined the 
control groups and combined the different time point outcomes within studies. The pooled OR of APR for the 
intervention group was 0.65 (95% CI 0.49-0.86; P=0.003). However, significant heterogeneity was observed 
(I2=66%) as a result of differences in design, population, and intervention details. 
Effects of intervention strategies (Figure 3)  
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Among the clinician interventions four of nine studies used guidelines for respiratory infections and two used 
APR feedback to clinicians.  Delayed prescription was used in one study. Three studies used patient-clinician 
communication skills training. Training and workshops lasted from 40 minutes to two days. Training lasted <1 
day in 6 studies and >1 day for the remaining 3.  Printed leaflets/posters were used in three of eight studies 
involving parents. Three studies used patient-clinician communication intervention. Two studies used video in 
waiting areas, lasting five to eight minutes.  
Meta-analysis showed that the pooled OR for all types of interventions with clinicians was 0.65 (95% CI 0.54-
0.79; I2=44%), for patient-clinician communication approach was 0.41 (95% CI 0.20-0.83; I2=73%), for APR 
feedback was 0.65 (95% CI 0.49-0.87; I2=0%), for delayed prescription was 0.86 (95% CI 0.65-1.13;n=1), for 
guideline use was 0.68 (95% CI 0.53-0.88; I2=21%). Though there were overlaps in 95% CI, testing for 
subgroup interaction was insignificant (p=0.2).  
For intervention types with parents, the pooled OR for all was 0.55 (95% CI 0.36-0.84; I2=36%), for video was 
0.86 (95% CI 0.56-1.31; I2=0%), for leaflets/posters the pooled OR was 0.74 (95% CI 0.49-1.12; I2= 0%), for 
patient-clinician conmmunication was 0.26 (95% CI 0.08-0.91; I2=86%). No significant subgroup difference 
was found.  
Effects of interventions through targeted group, study design, study year, follow-up duration and intensity of 
intervention and ICC report (Table 3) 
When studies were grouped according to the intervention target, four studies targeting clinicians achieved a 
pooled OR of 0.88 (95% CI 0.67-1.16; I2=73%). Three studies targeting parents achieved an OR of 0.50 (95% 
CI 0.10-2.51; I2=80%). A total of five studies that had interventions targeting both groups achieved a pooled OR 
of 0.52 (95% CI 0.34-0.79; I2=50%).   
For studies with different designs, the pooled OR for all RCTs (including cluster RCTs) was 0.56 (95% CI 0.41-
0.78; I2 =74%). Non-randomized controlled trials had similar pooled OR 0.84 (95% CI 0.61-1.17; I2 =0%). Five 
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studies were conducted in 2010s and seven were in 2000s. The pooled OR was for studies conducted in 2000s 
was 0.59 (95% CI 0.36-1.00; I2 =66%) and for studies in 2010s was 0.66 (95% CI 0.49-0.89; I2 =72%).  
For studies with different follow-up durations, six had follow-up durations from 1-6 months, with a pooled OR 
of 0.62 (95% CI 0.43-0.90, I2 =77%) while the pooled OR for the other six studies with follow-up durations 
from 7-12 months was 0.59 (95% CI 0.45-0.79, I2 =17%). For the nine face to face training studies the pooled 
RR was 0.77 (95% CI 0.65-0.92;  I2=36%), while three studies with written or online training had a pooled OR 
of 0.38 (95% CI 0.21-0.70;  I2=44%). However subgroup interaction here was significant (p=0.03).  
When evaluating only cluster trials, the results were similar to including all studies. Studies that reported ICC 
achieved a pooled OR 0.52 (n= 4, 95% CI 0.33-0.84; P= 0.007; I2=76%) while studies with unreported ICC had 
a higher OR 0.81 (n=5, 95% CI 0.67-0.98; I2=13%). Pediatric clinical settings achieved a pooled OR of 0.61 (95% 
CI 0.47-0.79; I2=0%), which was similar to non-pediatric settings 0.60 (95% CI 0.43-0.85; I2=74%). 
Meta regression  
To explore factors that might contribute to heterogeneity between studies, we also conducted meta-regressions 
on target group, follow-up duration, study design, study setting and study years, respectively for all included 
studies. However, none of these factors were associated with between-study heterogeneity. Also when only 
considering cluster studies, none of these variables or additionally, ICC reported or unreported or study setting 
were associated with between-study heterogeneity. 
Sensitivity analysis  
We used three different ICCs to assess all cluster studies (ICC=0.04; ICC=0.02; ICC=0.2) without a reported 
ICC according to the following factors: target of intervention, study design, follow-up duration and study year 
for all studies and only cluster studies. Results were consistent across the three ICCs.  
Sensitivity analysis on individual studies revealed that there was no change in heterogeneity after omitting any 
of the included articles.  
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Publication bias  
Results from Egger’s regression test revealed publication bias was not significant (p=0.214) 
Discussion  
We have found that clinician-parent communication intervention appeared to have the strongest effect 
compared to other approaches. APR feedback and updated guidelines were effective in reducing APR for 
childhood URIs. Targeting both clinicians and parents was more effective compared with targeting either group 
alone. Among cluster trials, those with reported ICC had a stronger effect. None of the following factors: 
intervention target, follow-up duration, design, years, clinical setting, and reported or unreported ICC were 
associated with residual variation due to heterogeneity. This is probably due to the presence of multiple sources 
of heterogeneity as well as difficulty in measuring sources of heterogeneity. However, heterogeneity declined 
by subgroup, with heterogeneity for intervention with clinicians at 44% while that for interventions with parents 
was 36%.  
Previous systematic reviews were conducted to explore the effectiveness of interventions to reduce irrational 
antibiotic prescription in both adults and children with various diseases.3 4 7 21-24  The advantages of our review 
over others is that we focus on a specific population (children) and condition (URI) and stratified analyses 
according to the type of intervention, which enriched the existing literature as most of the previous studies were 
descriptive. Additionally, very few studies describe intervention approaches. We found that the lowest pooled 
ORs were seen in the clinician-parent communication approach, This is consistent with the review by Davey 11 
et al for hospital inpatients. Davey found that clinician-targeted intervention using interactive meetings 
appeared more effective than didactic lectures, improved laboratory resources and consultation with specialists.  
Combined interventions were found to be more effective than a single intervention alone 7 22 25 26. This review 
and prior research reached similar conclusions, in particular that the involvement of both physicians and parents 
was most effective. Vodicka 24 and Boonacker 26 both examined interventions to improve childhood antibiotic 
11 
 
prescription for respiratory infections.  However, neither review used meta-analysis to measure relative risk. 
Both concluded that multifaceted interventions can reduce antibiotic use, however providing printed materials 
and targeting only parents had limited effects, which is consistent with our results. A review conducted by 
Thoolen showed that education to decrease inappropriate antibiotic use was not effective despite increased 
patient knowledge, which is contrary to the findings from Arnold 7 and our analysis. We found the pooled OR 
for targeting parents was 0.50 though it was statistically insignificant with a higher I2. In these studies, the 
change in knowledge was the primary outcome, while very few studies had data for APR that could be included 
into the meta-analysis. Nevertheless education for parents could have a synergistic effect with clinician training 
and further reduce APR.28  
For cluster RCTs, within-study variation can also influence the effect through variation at the cluster level.29 We 
observed a stronger effect in studies where ICC was reported. A study that reports the ICC may have been more 
carefully designed with more consideration of study design.  
Our review has several strengths. First, to our knowledge, this is the first study to examine the effect of 
interventions through APR, which is ultimately the desired effect. Second, sensitivity analysis with 3 different 
ICC found trends to be consistent. Sensitivity analysis on excluding cluster non-randomized controlled trails 
had similar results, suggesting the study design had limited effect on the results. This suggests results were 
reliable. Third, the two studies with the widest confidence intervals targeted both clinicians and parents, and 
both were cluster RCTs. This may actually have led to under-estimation of the effect of this type of intervention, 
making the result more conservative. Fourth, we evaluated the association between interventions and APR 
under subgroups of 1) different approaches to clinicians and parents respectively; 2) study design and 3) study 
settings rather than just the overall effect, thus making our findings more specific. 
In terms of limitations, Firstly, non-randomized controlled trials had a higher selection bias than RCTs, while 
cluster RCTs had cluster level selection bias, although we calculated the cluster RCT studies ICC to adjust for 
design effects. It is impossible to avoid the nature of the existing selection bias within studies. Secondly, most of 
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the studies we reviewed had multifaceted interventions, which were mixed to maximize the effect, making it 
difficult to evaluate individual components. At the same time, prescription is not a single clinician behavior, but 
is influenced by different factors. This also increases the complexity of study design, which made data analysis 
complex and we could not analyze which intervention component is superior to the other. As no study provided 
feedback on the intervention implementation, it is difficult to know which component might contribute the 
most. Thirdly, no study was from a developing country, which limits generalizability.  
. 
For policy makers, we hope we have better characterized the optimal intervention design. Future efforts should 
focus on an interactive approach that includes both parents and clinicians, in addition to providing clinicians 
with information through feedback on their APR and guidelines. Communications skills between clinicians and 
parents should also be enhanced. Education for parents might facilitate improved communication. 
Future studies of the quality of intervention implementation are needed. Given the variability in the content and 
intensity of a given type of intervention, more research is needed to understand optimal content/intensity. This 
is needed for children especially, given the frequency of URI in this population and the paucity of available 
proven therapies. There is a need to evaluate future interventions in the context of continuously improving 
diagnostics and therapeutics. More evidence on intervention sustainability is needed and the acceptance of 
interventions should be further explored based on the local context, resources and cost-effectiveness studies. 
The interventions in these trials should be studied against a theoretical framework of health behavior change. 
Given the extent of antibiotic overuse in developing countries, further studies of interventions in these settings 
are needed. 
Words (3024)  
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Table 1.  Basic characteristics of the included studies (n=12) 
Study ID  Design  Settings/
No of 
clusters 
Follow-up 
duration   
Children 
age  
Participants Intervention  Control  Outcomes 
Esmaily 2010*#31 cRCT Iran/ 
110 
clusters 
3 months  Not 
described  
   
112 general  
practitioners 
(GPs) 
Target: Clinicians 
Approach: peer leaders 
training  
Content:principle of 
rational antibiotic use 
(guideline)  
Technic:16 hours workshop  
Control: lecture based 
training with  
traditional teaching 
method 
% prescriptions with antibiotics  
intervention: 61% to 63%  
Control: 59% to 60%   
Finkelstein 
2001*#18 (outcome 
for age 3-36 
months, outcome 
for 36-72 months  
cRCT US/ 
12 clusters 
 
12 months 3 months 
to 72 
months  
 
157 practice 
clinicians; 
13460 
patients 
Target: Both clinicians and 
parents   
Approach  
to clinicians: update 
guideline,  peer leaders 
training 
to parents: leaflets/posters; 
No educational  
intervention and no  
feedback 
The rate of antimicrobial prescribing per 
person year in the Intervention: decreased 
by 41% 
control: decreased by 33%  
What is already known on this subject? 
Antibiotic resistance is a global public health crisis, due in part to over-prescribing of antibiotics, 
which is common for childhood URIs. Systematic reviews show interventions with providers 
reduce antibiotic prescription, but with conflicting results about interventions with parents. Little 
is known about the relative benefits of each intervention, and no meta-analyses have been 
published. 
What the study adds: 
In order to reduce antibiotic prescription for childhood URIs, the most effective interventions 
involve both clinicians and parents. Improved communication between clinicians and parents is an 
essential part of antibiotic stewardship for childhood URIs.  
  
15 
Technic: 90 minutes’ small 
group education  
 
 
Francis 2009*32 cRCT  UK/ 
61 clusters 
7 months  6 months 
to 14 
years  
108 practice 
clinicians; 
558 patients 
Target: Both clinicians and 
parents  
Approach to both: 
 Content: patient-clinician 
communication   
Technic :40 minutes online 
training  
Usual care  Antibiotics were prescribed at the index 
consultation 19.5% in the intervention 
group and 40.8% in the control group 
Gerber 2013*#33 cRCT  US/ 
18 clusters 
12 months  1-10 years  162 practice 
clinicians 
Target: Clinicians  
Content: updated 
guidelines; APR feedback 
Technic: 1 hour clinical 
training    
No education and 
prescribing  
feedback 
For acute sinusitis broad spectrum 
prescriptions in intervention: decreased 
from 38.9% to 18.8% 
Control: decreased from 40.0% to 33.9%  
Gjelstad 2013*34 cRCT Norway/ 
79 clusters 
6 months  <18 years  
 
382 practice 
clinicians 
Target: Clinician 
Approach: peer leaders 
training; 
Content: Delayed 
prescriptions  
Technic:One day seminar 
Control: received 
intervention targeting 
appropriate drug use 
but not antibiotics 
APR: Intervention:  decreased from 
33.2% to 31.85 Control: increased from 
33.4% to 35%  
 
Gonzales 
200519(two control 
groups) 
Cluster 
non- 
randomized 
controlled 
trial 
US/ 
7 clusters 
3 months  0-17 years  578 practice 
clinicians 
Target: Both Clinician and 
parents  
Approach 
 to clinicians: Content: 
APR feedback,  
to parents: Leaflets/posters 
Technic: Mail the 
information 
Physician education 
only, two controls: 
local and distance 
practices  
Adjusted antibiotic prescription rates: 
Distant control increased from 38% to 
39%  
Local control decreased from 39% to 
37% 
Intervention decreased from 34% to 30%  
Juzych 200535 Cluster 
non- 
randomized 
controlled 
trial 
US/ 
4 clusters 
5 months  <15 years  30 clinic 
physicians; 
15 internists 
Target: Clinician  
Approach: Content: clinical 
guideline;  
Technic: half day education  
No educational 
interventions 
Change in antibiotic prescription rate in 
Intervention: reduced by 35.2% 
Control: increased by 6.5% 
Legare 2012*36 cRCT Canada/ 
9 clusters 
5 months  8 months - 
9 years  
149 
physicians; 
359 eligible 
Target: Both clinician and 
parents  
Approach: peer leaders 
training; Patient-clinician 
Usual care  % patients deciding to use antibiotics 
Intervention: decreased from 40% to 
  
16 
patients communication  
Technic: two hours online 
workshop  
27.1% 
Control: increased from 36.8% to 65.5%  
Pshetizky 200337 RCT Israel 3 months  3 months 
to 4 years  
2 primary 
care clinics 
81 parents 
Target: Parents 
Approach: content: Patient-
clinician communication 
Method:short explanation  
No brief explanation 
given to parents 
 
Parents administered antibiotics to their 
children in Intervention: 37% 
Control: 63%  
Regev-Yochay 
2011*20(4 follow-
up time points  
outcomes)  
cRCT Israel/ 
50 clusters 
12, 24, 36, 48 
months  
<18 years   
 
Primary care 
pediatricians; 
97699 
registered 
children 
Target: Both clinician and 
parents 
Approach to clinicians: 
Year1: peer leaders training 
content:guideline ; 
Technic:2 days workshop, 
Year2: content:Patient-
clinician communication ; 
Technic:workshop Year3: 
APR feedback; 
Technic:workshop   
to parents : leaflets/poster;  
 
No intervention  APRs reduced by 22% in the control 
group, by 40% in the intervention group  
  
Taylor 20058 RCT US 12 months  <24 
months  
Pediatricians 
in Seattle 
Parents of 499 
eligible 
children 
Target: Parents  
Approach: Videos  
Parents received  
educational leaflets 
regarding effective 
injury prevention 
Total no. of prescriptions for antibiotics 
in Intervention: 2.2±2.6 
Control: 2.5±2.9 
Wheeler 200139 
 
Non-
randomized 
controlled 
trial 
US 9 months  <19 years  5 pediatric 
practices; 
9 physicians; 
771 parents 
Target: Parents  
Approach: Videos  
Leaflets/posters 
A control video on the 
dangers of stimulant 
use played to parents 
in the waiting areas;   
APR for viral infection reduced from 
6.8% to 4.2% in the intervention  
 Note: * Studies in which the number of children were prescribed any antibiotics from both groups, as well as the total number of children in each group were recalculated after adjustment for design effect (DE). # For CRCTs 
that had no ICCs reported, we estimated from similar study as supported by the evidences from Adams et al. in their article "Patterns of intra-cluster coORelation from primary care research to inform study design and 
analysis".               
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Table 2. Summary of risk of bias of included studies (n=12)  
Study ID  
Sequence 
generation 
Allocation 
concealment 
Blinding participants and 
personnel 
Blinding  
of outcome 
assessment 
Incomplete 
 outcome 
data 
Selective 
 outcome 
reporting 
Other 
bias 
Summary 
of 
 risk of bias 
Gerber 2013 + + - - ? + ? Low risk 
Gjelstad 2013 + + ? ? + ? + Low risk 
Juzych 2005 - + + ? + + ? High risk 
Esmaily 2010 - + + + + + + Low risk 
Pshetizky 2003 + + + ? + - + Low risk 
Taylor 2005 + + + ? + + ? Low risk 
Wheeler 2001 - - - ? + - - High risk 
Legare 2012 + + - + + - ? Low risk 
Francis 2009 + + - + + + + Low risk 
Gonzales 2005 - + - ? + + ? High risk 
Regev-Yochay 
2011 + ? - ? + + + 
Low risk 
Finkelstein 2001 + + + ? + + + Low risk 
Note: + = Low risk, ?= Unclear risk, -= high risk; Other bias: possible intervention contamination, recruitment bias, data collection bias.    
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Table 3. Results of meta-analysis of all included studies 
Subgroup  No of study  OR (95% CI)  
Heterogeneity  
I2 p 
Overall  12 * 0.65(0.49,0.86) 66% <0.001 
Study target  
Clinicians 4 0.88(0.67,1.16) 73% 0.010 
Parents 3 0.50(0.10,2.51) 80% 0.007 
Both  5 0.52(0.34,0.79) 50% 0.009 
Study design  
    cRCT 9 0.56(0.41,0.78) 74%     <0.001 
Non-R control trial 3 0.84(0.61,1.17) 0% 0.551 
Follow-up duration      
1-6 months  6 0.62(0.43,0.90)  77% <0.001 
7-12 months  6 0.59(0.45,0.79) 17% 0.300 
Intervention 
intensity      
<1 day 9 0.52(0.33,0.81) 66% 0.04 
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≥ 1 day 3 0.79(0.64,0.98) 50% 0.13 
Intervention 
method@      
Face to face training  6 0.77(0.65,0.92) 36% 0.160 
Non face to face 
training  3 0.38(0.21,0.70) 44% 0.170 
ICC report  * 
ICC reported   4 0.52(0.33,0.84) 76% 0.006 
No ICC reported 5 0.81(0.67,0.98) 13% 0.330 
Study year  
    2000s  7 0.59(0.35,1.00) 66% 0.007 
2010s  5 0.66(0.49,0.89) 72% 0.006 
Clinical settings     
Pediatric clinic 4 0.61(0.47,0.79)  0% 0.470 
Non-pediatric clinic 8 0.60(0.43,0.85)    74% <0.001 
 *ICC report studies only included the cluster studies .  @ Intervention method used only for the studies targeting clinicians.  
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Figure 1. Summary of included and excluded relevant articles in the review process. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: CENTRAL= the Cochrane Central Register of Controlled Trials.
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Full-text articles excluded 
(n = 360) 
No children involved (n= 
198) 
No URIs involved (n=81) 
No education intervention 
involved (n=33) 
No APR calculated (n=46) 
No data available to extract 
(n=2) 
  
Full-text articles 
assessed for eligibility  
(n =372) 
Studies identified through database 
MEDLINE, EMBASE, CENTRAL   
(n =5823) 
Additional studies through Google 
Scholar, dissertation abstracts 
international, published conference 
proceedings  
(n = 851) 
Abstract after duplicates removed  
(n =6074) 
Studies included in 
meta-analysis  
(n =12) 
Studies excluded (n=5701) 
Review excluded 
 (n=899) 
Not antibiotic prescription 
related 
(n=1443) 
No intervention for antibiotic 
prescription 
(n=3359) 
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Figure 2. Pooled relative risk (OR) and 95% confidence interval (CI) for reducing antibiotic prescription on childhood URIs 
  
 
Figure 3. Forest plot results across different intervention types for clinicians and parents.  
NOTE: Weights are from random effects analysis
Overall  (I-squared = 66.5%, p = 0.001)
Regev-Yochay2011
Legare2012
Gerber2013
Finkelstein2001
Taylor2005
Juzych2005
Gjelstad2013
Francis2009
Gonzales2005
ID
Pshetizky2003
Wheeler2001
Esmaily2010
Study
0.63 (0.50, 0.81)
0.61 (0.45, 0.84)
0.19 (0.07, 0.53)
0.49 (0.28, 0.84)
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0.88 (0.57, 1.37)
0.86 (0.59, 1.24)
0.87 (0.66, 1.14)
0.35 (0.18, 0.68)
0.70 (0.36, 1.37)
OR (95% CI)
0.11 (0.04, 0.33)
0.63 (0.14, 2.72)
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100.00
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8.72
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10.32
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Weight
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1.0354 28.3
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p= test for overall effect. 
0.65(95%CI 0.49-0.87; p=0.004)
0.86(95%CI 0.65-1.13; p=0.27)
0.41(95%CI 0.20-0.83; p=0.01)
0.68(95%CI 0.53-0.88; p=0.003)
0.63(95%CI 0.54-0.79; p<0.001)
-1.5 -1 -0.5 0 0.5 1 1.5
APR feedback
Delayed prescriptions
Patient-clinician
conmmunication
Guidelines
total
Intervention approach for clinicians
intervention  Control  
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p= test for overall effect. 
 
 
 
0.26(95%CI 0.08-0.91; p=0.66)
0.74(95%CI 0.49-1.12; p=0.16)
0.86(95%CI 0.56-1.31; p=0.48)
0.55(95%CI 0.36,0.84; p=0.006)
-1.50 -1.00 -0.50 0.00 0.50 1.00 1.50
Patient-clinician
communication
leaflets/posters
Videos
Total
Intervention approach for parents  
intervention  Control  
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